Literature DB >> 5283935

Spontaneous precipitation of brushite in urine: evidence that brushite is the nidus of renal stones originating as calcium phosphate.

C Y Pak, E D Eanes, B Ruskin.   

Abstract

Further evidence that brushite plays a regulatory role in renal stone formation was provided by the identification of brushite as the first precipitate that appears in supersaturated urine by spontaneous precipitation. Calcium chloride was added to induce supersaturation in urine specimens from twelve subjects with and twelve subjects without nephrolithiasis. The first precipitate in all specimens with pH below 6.9 was identified as brushite by x-ray diffraction and shown to have a calcium-phosphorus ratio of approximately 1.0. The activity product of [Ca(2+)] x [HPO(4) (2-)] necessary to produce a precipitate ranged from 2.2 to 3.5 times the solubility product of brushite, but the range and mean were the same for both groups of subjects. The activity product of [Ca(2+)] x [HPO(4) (2-)] in the supernatant (after spontaneous precipitation) was not significantly different from that obtained after incubation of the same urine specimen with synthetic brushite. These results provide conclusive evidence that brushite constitutes the solid phase formed by spontaneous precipitation from acidic urine supersaturated with respect to calcium and phosphorus; they suggest that the nidus for calcium-containing renal stones is brushite as well.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5283935      PMCID: PMC389216          DOI: 10.1073/pnas.68.7.1456

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Isolation from urine of pyrophosphate, a calcification inhibitor.

Authors:  H FLEISCH; S BISAZ
Journal:  Am J Physiol       Date:  1962-10

2.  Idiopathic hypercaicuria.

Authors:  P H HENNEMAN; P H BENEDICT; A P FORBES; H R DUDLEY
Journal:  N Engl J Med       Date:  1958-10-23       Impact factor: 91.245

3.  Calcification of collagen by urine in vitro: dependence on the degree of saturation of urine with respect to brushite.

Authors:  C Y Pak; B Ruskin
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

4.  Organic matrix of human urinary concretions.

Authors:  W H Boyce
Journal:  Am J Med       Date:  1968-11       Impact factor: 4.965

5.  Activity products in stone-forming and non-stone-forming urine.

Authors:  W G Robertson; M Peacock; B E Nordin
Journal:  Clin Sci       Date:  1968-06       Impact factor: 6.124

6.  Effect of the oral administration of ammonium chloride, sodium phosphate, cellulose phosphate and parathyroid extract on the activity product of brushite in urine.

Authors:  C Y Pak; J W Cox; E Powell; F C Bartter
Journal:  Am J Med       Date:  1971-01       Impact factor: 4.965

7.  Renal stones of calcium phosphate: physicochemical basis for their formation.

Authors:  C Y Pak; E C Diller; G W Smith; E S Howe
Journal:  Proc Soc Exp Biol Med       Date:  1969-03

8.  Peptide inhibitors of calcium phosphate precipitation in the urine of normal and stone-forming men.

Authors:  W G Robertson; J Hambleton; A Hodgkinson
Journal:  Clin Chim Acta       Date:  1969-08       Impact factor: 3.786

9.  The recognition and isolation from urine and serum of a peptide inhibitor to calcification.

Authors:  J E Howard; W C Thomas; L M Barker; L H Smith; C L Wadkins
Journal:  Johns Hopkins Med J       Date:  1967-03

10.  Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite.

Authors:  C Y Pak
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

View more
  18 in total

Review 1.  Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.

Authors:  Makoto Kuro-o
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

2.  Biochemical aspects of urinary stones.

Authors:  G A Rose
Journal:  Proc R Soc Med       Date:  1977-08

Review 3.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

Review 4.  Brushite stone disease as a consequence of lithotripsy?

Authors:  Amy E Krambeck; Shelly E Handa; Andrew P Evan; James E Lingeman
Journal:  Urol Res       Date:  2010-07-10

5.  Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.

Authors:  P O Schwille; D Scholz; E Hanisch; E Zeuner; H Schwendtner; B Husemann; E Mühe; A Sigel
Journal:  Klin Wochenschr       Date:  1983-09-01

6.  Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.

Authors:  Steeve Doizi; John R Poindexter; Margaret S Pearle; Francisco Blanco; Orson W Moe; Khashayar Sakhaee; Naim M Maalouf
Journal:  J Urol       Date:  2018-07-20       Impact factor: 7.450

7.  Urine saturation with calcium salts in normal subjects and idiopathic calcium stone-formers estimated by an improved computer model system.

Authors:  M Marangella; P G Daniele; M Ronzani; S Sonego; F Linari
Journal:  Urol Res       Date:  1985

8.  Calcium phosphate: an important crystal phase in patients with recurrent calcium stone formation?

Authors:  H G Tiselius; L Larsson
Journal:  Urol Res       Date:  1993-05

9.  Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones.

Authors:  Andrew P Evan; James E Lingeman; Elaine M Worcester; Andre J Sommer; Carrie L Phillips; James C Williams; Fredric L Coe
Journal:  Anat Rec (Hoboken)       Date:  2014-01-30       Impact factor: 2.064

10.  An understanding of renal stone development in a mixed oxalate-phosphate system.

Authors:  Xiangying Guan; Lijun Wang; Anja Dosen; Ruikang Tang; Rossman F Giese; Jennifer L Giocondi; Christine A Orme; John R Hoyer; George H Nancollas
Journal:  Langmuir       Date:  2008-06-17       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.